Emerging Contributions of Cancer/Testis Antigens to Neoplastic Behaviors

Research output: Contribution to journalReview article

5 Scopus citations

Abstract

Tumors of nearly every origin activate the expression of genes normally restricted to gametogenic cells. These genes encode proteins termed cancer/testis (CT) antigens, since expression outside of their naturally immune-privileged site can evoke an immune response. Despite extensive efforts to exploit CT antigens as immunotherapeutic targets, investigation of whether these proteins participate in tumorigenic processes has lagged. Here, we discuss emerging evidence that demonstrates that CT antigens can confer a selective advantage to tumor cells by promoting oncogenic processes or permitting evasion of tumor-suppressive mechanisms. These advances indicate the inherent flexibility of tumor cell regulatory networks to engage aberrantly expressed proteins to promote neoplastic behaviors, which could ultimately present novel therapeutic entry points.

Original languageEnglish (US)
Pages (from-to)701-712
Number of pages12
JournalTrends in Cancer
Volume4
Issue number10
DOIs
Publication statusPublished - Oct 1 2018

    Fingerprint

Keywords

  • cancer germline genes
  • cancer/testis antigens
  • CT antigen function
  • CT antigens
  • CT genes
  • tumor antigens

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this